Cargando…
Association between FGF19, FGF21 and lipocalin-2, and diabetes progression in PCOS
Women with polycystic ovary syndrome (PCOS) have an increased risk of developing type 2 diabetes. FGF19, FGF21 and lipocalin-2 have emerged as important markers of metabolic risk. This study aims to compare the levels of FGF19, FGF21 and lipocalin-2 between subjects with or without PCOS, and to inve...
Autores principales: | Cheng, Feifei, Ng, Noel Yat Hey, Tam, Claudia Ha Ting, Zhang, Yuying, Lim, Cadmon King Poo, Jiang, Guozhi, Ng, Alex Chi Wai, Yau, Tiffany Tse Ling, Cheung, Lai Ping, Xu, Aimin, Chan, Juliana C N, Ma, Ronald C W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8494400/ https://www.ncbi.nlm.nih.gov/pubmed/34473082 http://dx.doi.org/10.1530/EC-21-0082 |
Ejemplares similares
-
FGF19 subfamily members: FGF19 and FGF21
por: Dolegowska, Katarzyna, et al.
Publicado: (2019) -
Fundamentals of FGF19 & FGF21 Action In Vitro and In Vivo
por: Adams, Andrew C., et al.
Publicado: (2012) -
FGF19 and FGF21: In NASH we trust
por: Talukdar, Saswata, et al.
Publicado: (2020) -
Lipocalin-2 is associated with FGF23 in WNT1 and PLS3 osteoporosis
por: Loid, Petra, et al.
Publicado: (2022) -
FGF19 and FGF21 for the Treatment of NASH—Two Sides of the Same Coin? Differential and Overlapping Effects of FGF19 and FGF21 From Mice to Human
por: Henriksson, Emma, et al.
Publicado: (2020)